Cogent Biosciences Stock Soars: A Year of Gains and a $4.5M Sell
Cogent Biosciences has delivered staggering gains in a single year, yet a major fund recently trimmed its stake by mi...
Choosing the right funds for a retirement portfolio requires balance of cost and coverage. Review 2024 options and practical selection tips.
26,319 articlesCogent Biosciences has delivered staggering gains in a single year, yet a major fund recently trimmed its stake by mi...
As the 10-year yield hovers near 4.4%, many investors chase top-yield REITs for income. The real cost chasing reit be...
A branding blitz in national institutions and currency could quietly shift how you plan your money. This article brea...
On a day shaped by geopolitical optimism, the stock market today showed modest gains as investors priced in the poten...
Dividend income from the S&P 500 has been hard to come by. With the 500's dividend yield hasn't, investors are lookin...
The Nasdaq has slipped into correction territory, raising questions about the next move. This guide uncovers historic...
As a new era at the Fed begins, chair kevin warsh yearns for sweeping reforms even as two price shocks complicate the...
Retirees often weigh Medicare Advantage against Original Medicare. Here’s a practical, numbers-backed guide to decide...
When a large hedge fund reduces its Celcuity stake, markets pay attention. This article breaks down the move, what it...
Venture funding in the U.S. hit a record in the first half of 2026, led by AI mega-deals, while exits skew toward Spa...
QYLD offers a headline 12% yield through its covered-call strategy, yet 10-year total returns lag the Nasdaq-100 and ...
Netflix slid on reports about missed media bids and potential lawsuits, sending ripples through the market. This guid...